Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New cyclin-dependent kinase inhibitors in the Boehringer Ingelheim pipeline

Nov. 3, 1999

Semisynthetic ecteinascidins presented in recent patent issued to U. of Illinois

Nov. 3, 1999

Celecoxib in FAP: results of clinical trial discussed at ACG

Nov. 2, 1999

AxyS Pharmaceuticals licenses rights to Signal's SERM-beta compounds for cancer indications

Nov. 2, 1999

Development of antisense-containing regimen for malignant melanoma to be fast-tracked

Oct. 29, 1999

Paracure gets notice of allowance for patent covering modified arglabin compounds

Oct. 29, 1999

CPMP gives favorable opinion on Taxotere for advanced non-small cell lung cancer

Oct. 28, 1999

Additional positive data reported for Cell Pathways' exisulind

Oct. 28, 1999

First macrolide LHRH antagonists patented by Abbott

Oct. 28, 1999

New distamycin derivatives developed at Pharmacia & Upjohn for cancer Rx

Oct. 28, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...